ZOLGENSMA

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: c2b9cc0078ce3ca3
Drug Approval Canada Name: ZOLGENSMA
Product Name: ZOLGENSMA
Status: Marketed
Status Date: 2021-02-04
Original Market Date: 2021-02-04
Din: 02509695
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 26:12.00
Atc Original: M09AX09 ONASEMNOGENE ABEPARVOVEC
Atc Name: m 09 ax 09
Aig Number: 0162641001
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

ONASEMNOGENE ABEPARVOVEC

20000000000000 VG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c2b9cc0078ce3ca3

Type

Standard